5‐Chloro‐2,4‐dihydroxypyridine, CDHP, prevents lung metastasis of basal‐like breast cancer cells by reducing nascent adhesion formation

By  

Cancer Medicine, Vol. 7, Iss. 2, 2018-02 ,pp. : 463-470

John Wiley & Sons Inc

Access to resources Recommend Favorite

The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer

By Mizutani Y.   Wada H.   Fukushima M.   Yoshida O.   Ukimura O.   Kawauchi A.   Miki T.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 569-575

Elsevier

Access to resources Recommend Favorite

Dihydropyrimidine dehydrogenase and fluoropyrimidines: a review of current dose adaptation practices and the impact on the future of personalized medicine using 5-fluorouracil

By Boisdron-Celle Michèle   Biason Paola   Gamelin Erick   Morel Alain  

Colorectal Cancer, Vol. 2, Iss. 6, 2013-12 ,pp. : 549-558

Future Medicine

Access to resources Recommend Favorite

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

By Van Cutsem E.   Cunningham D.   Ten Bokkel Huinink W.W.   Punt C.J.A.   Alexopoulos C.G.   Dirix L.   Symann M.   Blijham G.H.   Cholet P.   Fillet G.   Van Groeningen C.   Vannetzel J.M.   Levi F.   Panagos G.   Unger C.   Wils J.   Cote C.   Blanc C.   Herait P.   Bleiberg H.  

European Journal of Cancer, Vol. 35, Iss. 1, 1999-01 ,pp. : 54-59

Elsevier

Access to resources Recommend Favorite

Antitumour Activity, Toxicity and Inhibition of Thymidylate Synthase of Prolonged Administration of 5-Fluorouracil in Mice

By Codacci-Pisanelli G.   van der Wilt C.L.   Pinedo H.M.   Franchi F.   Noordhuis P.   Braakhuis B.J.M.   van Laar J.A.M.   Peters G.J.  

European Journal of Cancer, Vol. 31, Iss. 9, 1995-09 ,pp. : 1517-1525

Elsevier

Access to resources Recommend Favorite